GlassScriptPhysician profile
Sonu Mody
NPI 1114458544
$1,364.43
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $89.01 · 2021: $683 · 2022: $577 · 2024: $15.14.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $15.14.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $15.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $303.58 | 2021-2022 | |
| Novo Nordisk INC | $234.16 | 2020-2022 | |
| Janssen Pharmaceuticals, INC | $119.00 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $114.34 | 2021-2022 | |
| Abbvie INC. | $113.29 | 2021-2022 | |
| Mannkind Corporation | $65.40 | 2021-2022 | |
| Aspira Women'S Health INC | $64.70 | 2022 | |
| Lilly USA, LLC | $44.77 | 2021-2022 | |
| Horizon Therapeutics Plc | $43.21 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $40.21 | 2021-2022 | |
| Pfizer INC. | $30.06 | 2021-2024 | |
| Novartis Pharmaceuticals Corporation | $26.98 | 2021 | |
| Abbott Laboratories | $19.86 | 2022 | |
| Sunovion Pharmaceuticals INC. | $18.27 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $15.00 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $14.91 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $14.15 | 2022 | |
| Nabriva Therapeutics, Plc | $13.63 | 2021 | |
| Currax Pharmaceuticals LLC | $13.25 | 2022 | |
| Amarin Pharma, INC. | $12.90 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sonu Mody listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.